Summary of Study ST002905

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001773. The data can be accessed directly via it's Project DOI: 10.21228/M8J420 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002905
Study TitlePorphyrin analysis of K562 cells following C13-Serine and C13-Glycine tracing during folate depletion.
Study SummaryCulture of K562 cells for 7 days in RPMI media containing 2000 nM folic acid or 100 nM folic acid. At day 8, media was changed to 2000 nM or 100 nM folic acid with unlabeled serine and glycine, or 2-C13-Serine and 2-C13-Glycine at RPMI levels. Amino acid tracing was performed for 24 hours. These samples were followed up by metabolomics targeting porphyrin metabolites.
Institute
Boston Children's Hospital, Harvard Medical School
Departmentpathology
LaboratoryKanarek Lab
Last NameKanarek
First NameNaama
AddressEnders 1116.2, 300 Longwood Ave, Boston, MA 02115
Emailnaama.kanarek@childrens.harvard.edu
Phone6173557433
Submit Date2023-10-02
Num Groups5
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2024-02-13
Release Version1
Naama Kanarek Naama Kanarek
https://dx.doi.org/10.21228/M8J420
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001773
Project DOI:doi: 10.21228/M8J420
Project Title:Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis
Project Summary:Folate, an essential vitamin, is a one-carbon acceptor and donor in key metabolic reactions. Erythroid cells harbor a unique sensitivity to folate deprivation, as revealed by the primary pathological manifestation of nutritional folate deprivation: megaloblastic anemia. To study this metabolic sensitivity, we applied mild folate depletion to human and mouse erythroid cell lines, and primary murine erythroid progenitors. We show that folate depletion induces early blockade of purine synthesis and accumulation of the purine synthesis intermediate and signaling molecule, AICAR, followed by enhanced heme metabolism, hemoglobin synthesis, and erythroid differentiation. This is phenocopied by inhibition of folate metabolism using the SHMT1/2 inhibitor - SHIN1, and by AICAR supplementation. Mechanistically, the metabolically-driven differentiation is independent of nucleotide sensing through mTORC1 and AMPK, and is instead mediated by protein kinase C (PKC). Our findings suggest that folate deprivation-induced premature differentiation of erythroid progenitor cells is a molecular etiology to folate-deficiency induced anemia.
Institute:Boston Children's Hospital, Harvard Medical School
Department:pathology
Laboratory:Kanarek Lab
Last Name:Kanarek
First Name:Naama
Address:Enders 1116.2, 300 Longwood Ave, Boston, MA 02115
Email:naama.kanarek@childrens.harvard.edu
Phone:(617) 355-7433

Subject:

Subject ID:SU003018
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Cell Strain Details:K-562

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Treatment
SA315921K562_100nM_FA_C13_Glycine_porphyrin_4100nM_FA_C13_Glycine
SA315922K562_100nM_FA_C13_Glycine_porphyrin_1100nM_FA_C13_Glycine
SA315923K562_100nM_FA_C13_Glycine_porphyrin_2100nM_FA_C13_Glycine
SA315924K562_100nM_FA_C13_Glycine_porphyrin_3100nM_FA_C13_Glycine
SA315925K562_100nM_FA_C13_Serine_porphyrin_1100nM_FA_C13_Serine
SA315926K562_100nM_FA_C13_Serine_porphyrin_2100nM_FA_C13_Serine
SA315927K562_100nM_FA_C13_Serine_porphyrin_4100nM_FA_C13_Serine
SA315928K562_100nM_FA_C13_Serine_porphyrin_3100nM_FA_C13_Serine
SA315929K562_100nM_FA_Unlabeled_porphyrin_3100nM_FA_Unlabeled
SA315930K562_100nM_FA_Unlabeled_porphyrin_1100nM_FA_Unlabeled
SA315931K562_100nM_FA_Unlabeled_porphyrin_2100nM_FA_Unlabeled
SA315932K562_100nM_FA_Unlabeled_porphyrin_4100nM_FA_Unlabeled
SA315933K562_2000nM_FA_C13_Glycine_porphyrin_12000nM_FA_C13_Glycine
SA315934K562_2000nM_FA_C13_Glycine_porphyrin_22000nM_FA_C13_Glycine
SA315935K562_2000nM_FA_C13_Glycine_porphyrin_32000nM_FA_C13_Glycine
SA315936K562_2000nM_FA_C13_Glycine_porphyrin_42000nM_FA_C13_Glycine
SA315937K562_2000nM_FA_C13_Serine_porphyrin_12000nM_FA_C13_Serine
SA315938K562_2000nM_FA_C13_Serine_porphyrin_42000nM_FA_C13_Serine
SA315939K562_2000nM_FA_C13_Serine_porphyrin_22000nM_FA_C13_Serine
SA315940K562_2000nM_FA_C13_Serine_porphyrin_32000nM_FA_C13_Serine
SA315941K562_2000nM_FA_Unlabeled_porphyrin_22000nM_FA_Unlabeled
SA315942K562_2000nM_FA_Unlabeled_porphyrin_32000nM_FA_Unlabeled
SA315943K562_2000nM_FA_Unlabeled_porphyrin_12000nM_FA_Unlabeled
SA315944K562_2000nM_FA_Unlabeled_porphyrin_42000nM_FA_Unlabeled
Showing results 1 to 24 of 24

Collection:

Collection ID:CO003011
Collection Summary:One million cells from culture were collected via centrifugation for 20 seconds at 18,000xG, washed with 0.9% NaCl, and collected via centrifugation for 20 seconds at 18,000xG
Sample Type:Cultured cells

Treatment:

Treatment ID:TR003027
Treatment Summary:Culture of K562 cells for 7 days in RPMI media containing 2000 nM folic acid or 100 nM folic acid. At day 8, media was changed to 2000 nM or 100 nM folic acid with unlabeled serine and glycine, or 2-C13-Serine and 2-C13-Glycine at RPMI levels. Amino acid tracing was performed for 24 hours. The level of serine and glycine in all conditions was 30 and 10 mg/L, respectively.

Sample Preparation:

Sampleprep ID:SP003024
Sampleprep Summary:One million cells from culture were collected via centrifugation, washed with 0.9% NaCl, and resuspended in 150 µl of porphyrin extraction buffer (1:4 ratio of 1.7 M HCl:ACN, 1µM deuteroporphyrin IX (Frontier Scientific, D510-9)) and 0.5 µM isotopically labeled amino acids (Cambridge Isotopes, MSK-A2-1.2)). Samples were vigorously shaken for 20 min at 16ºC in a thermomixer (Eppendorf), sonicated for 10 cycles at 4ºC with 30 sec on and 30 sec off, then incubated at 4ºC for 10 min. Following incubation on ice, samples were centrifuged for 10 minutes at 18,000g to pellet cell debris. The supernatant was collected and 40.5 µl super-saturated MgSO4 and 12 µl 5 M NaCl were added. Samples were vortexed for 30 sec and further shaken for 10 min at 16 ºC in a thermomixer. Finally, a 10 min 10,000 rpm centrifugation was used to separate the organic layer (upper) from the aqueous layer (lower). The upper organic layer was collected.

Combined analysis:

Analysis ID AN004768
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Vanquish
Column Phenomenex Kinetex C18 (150 x 3mm,2.6um)
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Q Exactive Orbitrap
Ion Mode POSITIVE
Units peak area

Chromatography:

Chromatography ID:CH003600
Chromatography Summary:Sample (5 uL) was injected onto a 2.6 μm, 150 x 3 mm C18 column (Phenomenex, 00F-4462-Y0) equipped with a 3.0 mm safe-guard column (Phenomenex, AJ0-8775). Column compartment was heated to 45 ºC. Porphyrins were separated with a chromatographic gradient at a flow rate of 0.800 ml min−1 as follows: 0–2 min: 5% B; 2-19min: linear gradient from 5% to 95% B; 19-21min: 95% B; 21.1-23min: return to 5% B.
Instrument Name:Thermo Vanquish
Column Name:Phenomenex Kinetex C18 (150 x 3mm,2.6um)
Column Temperature:45
Flow Gradient:linear gradient from 5% to 95%
Flow Rate:0.8 mL/min
Solvent A:95% water/5% acetonitrile; 0.1% formic acid
Solvent B:5% water/95% acetonitrile; 0.1% formic acid
Chromatography Type:Reversed phase

MS:

MS ID:MS004514
Analysis ID:AN004768
Instrument Name:Thermo Q Exactive Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:The mass spectrometer was operated in full-scan, positive ionization mode using a narrow-range scan: 450-700m/z, with an additional tSIM scan for hemin (616.1767 m/z), CoproP (655.2762 m/z), and PPIX (563.2653 m/z). Metabolites were relatively quantified while referencing an in-house library of chemical standards and using TraceFinder 4.1 (Thermo Fisher Scientific, Waltham, MA, USA), with a 5 ppm mass tolerance.
Ion Mode:POSITIVE
  logo